基于(关键地区、市场参与者、规模和份额)的生物成像市场 - 到 2031 年的预测

  • Report Code : TIPRE00004180
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计生物成像市场在 2023 年至 2031 年期间的复合年增长率为 5.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

该报告按技术(医学和分子)进行细分。此外,该报告还按最终用户(诊断中心和医院)进行细分。全球分析进一步细分为区域和主要国家。该报告以美元为单位提供了上述分析和细分的价值。

报告目的

Insight Partners 的《生物成像市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种商业利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

生物成像市场细分

 

技术

  • 医学和分子

最终用户

  • 诊断中心和医院

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

生物成像市场:战略洞察

Bio-imaging Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

生物成像市场的增长动力

  • 早期诊断需求激增:对多种疾病的早期诊断需求日益增长,这是生物成像市场的主要推动力之一。医疗保健提供商明白,在癌症或心血管系统等疾病的早期阶段进行治疗比后期治疗效果更佳。鉴于患者和临床医生都将注意力转向早期干预,因此大量先进的成像系统涌现,这些系统可以早期轻松地诊断疾病。
  • 先进成像技术的使用增加:生物成像市场正受到成像设备的快速发展推动,这些设备采用了高分辨率 MRI、更先进的超声波和分子成像技术等技术。这些进一步的发展使医疗专业人员能够获得更清晰的图像,从而实现出色的诊断和治疗模式。随着时间的推移,这些技术不断发展,也使临床医生能够更加轻松地在当今的医疗实践中利用生物成像。
  • 老龄人口不断增加:全球老龄人口不断增加是推动生物成像市场增长的主要因素之一。这是因为老年人更容易患慢性病或病情随着年龄增长而恶化,这使得他们更加依赖持续的诊断和先进的治疗程序。在这方面,老年人口激增导致人们寻求可行的生物成像方案,因为老年人医疗保健系统的管理侧重于提供优质服务。

生物成像市场未来趋势

  • 人工智能的入侵:人工智能在生物成像领域的整合通过改进图像的分析和解释,增强了医学诊断。人工智能技术被编程为快速搜索模式和不规则性,并且非常成功和快速地完成。这似乎促进了图像处理技术在自动化系统中的使用,从而减少了放射科医生的工作量并缩短了周转时间。毋庸置疑,随着人工智能的进步,它将有助于提高生物成像过程的效率以及患者的结果。
  • 即时诊断成像解决方案:即时诊断成像解决方案的出现显著改善了不同医疗机构对各种健康状况的诊断。例如,在便携式成像设备中,可以找到手持式超声波机器,它允许立即评估和决策,特别是在紧急情况下或难以到达的区域。这种趋势增加了成像服务的可用性并减少了等待时间,从而通过帮助根据最新信息快速做出改变来增强患者护理。
  • 关注个性化医疗的发展:个性化医疗越来越受欢迎,这是促进针对特定患者的生物成像技术创新发展的因素之一。一些先进的成像方法可以帮助了解疾病的不同特征,从而有助于设计针对特定疾病的治疗方法。这一趋势不仅提高了正确诊断的能力,而且旨在提高治疗效果,从而从人口健康管理转向关心患者个人的医疗保健,并积极寻求根据个体患者修改干预措施和结果。

生物成像市场机会

  • 新兴经济体的增长机会:新兴经济体正成为生物成像行业的潜在增长热点。随着医疗保健系统的完善和现代设备的普及,诊断成像服务预计将增长。可以利用这一趋势,与当地参与者建立合作关系,并根据这些国家/地区的实际情况修改其产品,以便更好地利用和渗透到该国市场。人工智能的结合:人工智能 (AI) 融入生物成像将改变游戏规则。人工智能可以帮助解释图像,帮助执行某些功能并协助诊断。从本质上讲,通过创建在运营中使用人工智能技术的成像解决方案,这些公司将解决医疗保健提供者过度劳累、改善患者场景和行业竞争的问题,从而为新想法和业务扩展腾出空间。个性化医疗的努力:鉴于妇科成像市场专注于更专业的诊断技术,它正在转向个性化医疗,这带来了一些机会。最新的成像技术可以揭示每个患者治疗机制的详细信息,从而可以采用适当的疗法,使治疗更容易。成像策略可以适应这种个性化医疗和治疗系统的发展,而开发这些策略的公司将确保他们在街头穿着巴拉克拉法帽、看起来相当危险的地位。

 

生物成像市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响生物成像市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生物成像市场细分和地理位置。

Bio-imaging Market
  • 获取生物成像市场的区域特定数据

生物成像市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)5.4%
史料2021-2022
预测期2024-2031
涵盖的领域按技术分类
  • 医学和分子
按最终用户
  • 诊断中心和医院
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • BioClinica 公司
  • 博莱科影像公司
  • 福纳公司
  • 拜耳医药保健公司
  • Covidien制药公司
  • Digirad 公司
  • 百胜公司
  • 日立医疗公司
  • Gamma Medica 公司

 

生物成像市场参与者密度:了解其对业务动态的影响

生物成像市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在生物成像市场运营的主要公司有:

  1. BioClinica 公司
  2. 博莱科影像公司
  3. 福纳公司
  4. 拜耳医药保健公司
  5. Covidien制药公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Bio-imaging Market

 

  • 了解生物成像市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了生物成像市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,生物成像市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors impacting the bio-imaging market?

Increasing number of diagnostic centers and radiopharmaceutics is the factor driving market growth

What are the key players operating in the bio-imaging market?

BioClinica, Inc.
, Bracco Imaging S.p.A
, FONAR Corporation are the key players operating in the bio-imaging market

Which segment accounts for highest revenue in product type in the market in 2023?

Medical segment accounts for highest revenue in product type in the market in 2023

What are the deliverable formats of the bio-imaging market?

The report can be delivered in PDF/Word format, we can also share excel data sheet based on request.

Based on geography, which region held the largest share of the bio-imaging market?

Based on geography, Asia Pacific held the largest share of the bio-imaging market.

What is the expected CAGR of the Bio-imaging Market?

The Bio-imaging Market is estimated to witness a CAGR of 5.4 % from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- BioClinica, Inc.
- Bracco Imaging S.p.A
- FONAR Corporation
- Bayer HealthCare Pharmaceuticals
- Covidien Pharmaceuticals
- Digirad Corporation
- Esaote S.p.A
- Hitachi Medical Corporation
- Gamma Medica Inc.
- GE Healthcare

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.